|1.||Liu, Y H: 3 articles (02/2014 - 06/2011)|
|2.||Stipkovits, L: 3 articles (06/2005 - 03/2001)|
|3.||Zhang, C Y: 2 articles (02/2014 - 06/2011)|
|4.||Deng, H: 2 articles (02/2014 - 02/2014)|
|5.||Yu, J J: 2 articles (02/2014 - 06/2011)|
|6.||Zhao, D H: 2 articles (02/2014 - 02/2014)|
|7.||Wang, R: 2 articles (01/2012 - 06/2011)|
|8.||Yu, Lu: 2 articles (10/2010 - 07/2009)|
|9.||Zhang, Xuemei: 2 articles (10/2010 - 07/2009)|
|10.||Deng, Xuming: 2 articles (10/2010 - 07/2009)|
02/01/2014 - "More attention should be given to monitoring the therapeutic efficacy and adverse effects of mixed infection because of higher required plasma drug concentration and enlarged AUC with valnemulin treatment."
07/01/2015 - "In vivo pharmacokinetic/pharmacodynamic profiles of valnemulin in an experimental intratracheal Mycoplasma gallisepticum infection model."
02/01/2014 - "A Mycoplasma gallisepticum-Escherichia coli mixed infection model was developed in broiler chickens, which was applied to pharmacokinetics of valnemulin in the present experiment. "
02/01/2014 - "Mycoplasma gallisepticum and Escherichia coli mixed infection model in broiler chickens for studying valnemulin pharmacokinetics."
07/15/2008 - "hyodysenteriae infections: valnemulin."
06/01/2015 - "Non-ERE related adverse events, including dysbacteriosis, enterotoxaemia and pneumonia, occurred in all groups at similar frequencies (untreated: 1.8%; 20 ppm valnemulin: 2.8%; 35 ppm valnemulin: 1.3%). "
09/01/1997 - "Providing that similar results are obtained in vivo under field conditions, valnemulin may well prove to be effective in the treatment of enzootic pneumonia and acute polyarthritis in pigs."
08/01/2014 - "In pigs, tiamulin and valnemulin are used to treat swine dysentery, spirochaete-associated diarrhoea, porcine proliferative enteropathy, enzootic pneumonia and other infections where Mycoplasma is involved. "
01/01/2013 - "Polyclonal and monoclonal antibodies against valnemulin, a new semi-synthetic antibiotic derivative of pleuromutilin administered to treat swine dysentery and pneumonia, were generated. "
06/01/2015 - "However, from days 7 to 21 of the outbreak, untreated rabbits had significantly lower daily weight gains and higher FCRs than medicated rabbits, suggesting a protective effect of valnemulin during the peak of the disease. "
06/01/2015 - "Administration of valnemulin did not affect feed consumption or body weight gain; treated rabbits had sustained weight gain and feed conversion rates (FCRs). "
10/01/2001 - "Based on the results of clinical observations (respiratory signs, rectal temperature, body weight gain, and feed conversion efficiency), macroscopic and histologic lesions of the lungs, and microbiologic findings, the best results were obtained by treatment of pigs with Econor + chlortetracycline, followed by Tetramutin, Pulmotil, Cyfac, and lincomycin + chlortetracycline."
|5.||Body Weight (Weight, Body)
07/01/2015 - "The PK of valnemulin after intramuscular (i.m.) administration at doses of 1, 10, and 20 mg/kg of body weight in M. "
02/01/2014 - "Covariate analysis indicated that body weight had a conspicuous effect on valnemulin clearance (CL/F). "
01/01/2012 - "1. A pharmacokinetic study of valnemulin was conducted in healthy Muscovy ducks after intravenous (IV), intramuscular (IM) and oral administrations at a dose rate of 15 mg/kg body weight. "
06/01/2011 - "The objective of this study was to investigate the pharmacokinetics and bioavailability of valnemulin in broiler chickens after intravenous (i.v.), intramuscular (i.m.) and oral administrations of 10 mg/kg body weight (bw). "
02/01/2014 - "The pharmacokinetics of valnemulin in infected chickens was determined by intramuscular (i.m.) injection and oral administration (per os, p.o.) of a single dose of 10 mg/kg body weight (BW). "
|7.||Anti-Bacterial Agents (Antibiotics)
|9.||Interleukin-10 (Interleukin 10)
|10.||Interleukin-6 (Interleukin 6)